Phase I/II study of oxaliplatin (L-OHP) plus 5-Fluorouracil concurrent with external beam radiotherapy (EBRT) in rectosigmoid carcinoma

被引：0
|
作者：
Cajal, TRY [1 ]
Rayo, SG [1 ]
Calvo, E [1 ]
Aristu, JJ [1 ]
Villafranca, E [1 ]
Cañón, R [1 ]
Moreno, M [1 ]
Hernández, JL [1 ]
Azinovic, I [1 ]
机构：
[1] Clin Univ, Dept Oncol, Pamplona 31008, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
239
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [31] Weekly Chemotherapy of 5-Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II Study
    Chen, Baoqing
    Li, Qiwen
    Li, Qiaoqiao
    Qiu, Bo
    Xi, Mian
    Liu, Mengzhong
    Hu, Yonghong
    Zhu, Yujia
    ONCOLOGIST, 2020, 25 (04): : 308 - +
  • [32] PHASE-II TRIAL OF 5-FLUOROURACIL PLUS MELPHALAN IN COLORECTAL CARCINOMA
    PRESANT, CA
    RATKIN, G
    KLAHR, C
    CANCER TREATMENT REPORTS, 1978, 62 (03): : 461 - 462
  • [33] PHASE II STUDY OF DOCETAXEL AND 5-FLUOROURACIL (5-FU) WITH CONCURRENT RADIOTHERAPY IN PATIENTS WITH ADVANCED ESOPHAGEAL CANCER
    Hihara, J.
    Hamai, Y.
    Emi, M.
    Aoki, Y.
    Miyata, Y.
    Okada, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 238 - 238
  • [34] Concurrent chemotherapy with 5-fluorouracil and carboplatin and external radiotherapy for inoperable esophageal carcinoma. A retrospective experience
    Gambaro, G
    Krengli, M
    Masini, L
    Turri, L
    Loi, G
    Prino, A
    Manara, M
    Oro, G
    Manfredda, I
    TUMORI, 2001, 87 (04) : S102 - S102
  • [35] A phase I/II study of cetuximab in combination with 5-fluorouracil (5-FU)/folinic acid (FA) plus weekly oxaliplatin (L-OHP) (FUFOX) in the first-line treatment of patients with metastatic colorectal cancer (mCRC) expressing epidermal growth factor receptor (EGFR). Preliminary results
    Hoehler, Thomas
    Dittrich, Christian
    Lordick, Florian
    Seufferlein, Thomas
    Riemann, Juergen F.
    Woell, Ewald
    Herrmann, Thomas
    Olchowka, Klaudia
    Kisker, Oliver
    Schmoll, Hans-Joachim
    ANNALS OF ONCOLOGY, 2004, 15 : 69 - 70
  • [36] Hypofractionated radiotherapy with concurrent 5-fluorouracil radiosensitisation for recurrent or locally advanced colorectal cancer - A phase II study
    Skarlatos, J
    Kosma, L
    Koukourakis, M
    Zambatis, C
    Kapsoritakis, A
    Mouder, N
    Yannakakis, D
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1996, 11 (05) : 206 - 210
  • [37] Induction FOLFOX followed by preoperative hyperfractionated radiotherapy plus bolus 5-fluorouracil in locally advanced rectal carcinoma: single arm phase I–II study
    Engy M. Aboelnaga
    Mohamed A. Daoud
    Entesar I. Eladl
    Amir M. Zaid
    Medical Oncology, 2015, 32
  • [38] Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer
    Jurado, M
    Martínez-Monge, R
    García-Foncillas, J
    Azinovic, I
    Aristu, J
    López-García, G
    Brugarolas, A
    GYNECOLOGIC ONCOLOGY, 1999, 74 (01) : 30 - 37
  • [39] Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study
    Pectasides, D
    Pectasides, A
    Farmakis, D
    Bountouroglou, N
    Nikolaou, M
    Koumpou, M
    Mylonakis, N
    Kosmas, C
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 537 - 542
  • [40] PHASE II STUDY OF PANITUMUMAB, OXALIPLATIN, 5-FLUOROURACIL AND CONCURRENT RADIOTHERAPY IN HIGH RISK LOCALLY ADVANCED RECTAL CANCER PATIENTS (STARPAN/STAR-02 STUDY)
    Pinto, C.
    Di Fabio, F.
    Maiello, E.
    Pini, S.
    Latiano, T.
    Aschele, C.
    Garufi, C.
    Bochicchio, A.
    Rosati, G.
    Aprile, G.
    Tassinari, D.
    Gennari, A.
    Giaquinta, S.
    Monteforte, M.
    Martoni, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 24 - 24
12345